CareCloud (MTBC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Achieved first positive GAAP net income since 2022, reporting $1.7M in Q2 2024 versus a $1.8M loss in Q2 2023, with strong free cash flow and significant debt repayment.
Adjusted EBITDA rose 67% year-over-year to $6.4M in Q2 2024, and adjusted net income more than doubled to $3.0M.
Revenue declined 4% year-over-year to $28.1M in Q2 2024, and six-month revenue was $54.1M, down 9% from 2023.
Cost reductions, restructuring, and suspension of preferred stock dividends improved profitability and liquidity.
Free cash flow for the first half of 2024 increased 265% year-over-year to $4.9M.
Financial highlights
Q2 2024 GAAP net income: $1.7M; adjusted net income: $3.0M ($0.18/share); adjusted EBITDA: $6.4M (23% of revenue).
Q2 2024 revenue: $28.1M, down from $29.4M year-over-year; six-month 2024 revenue: $54.1M, down from $59.4M in 2023.
Direct operating costs fell 13% year-over-year in Q2 2024; operating expenses down $2.9M year-over-year.
Net cash provided by operations for the six months was $8.3M, up 13% year-over-year.
Q2 2024 net loss attributable to common shareholders was $2.2M, or $(0.14) per share, improved from $(0.37) per share in Q2 2023.
Outlook and guidance
Management expects further profitability improvements and plans to eliminate remaining credit facility balance.
2025 focus will shift to growth, aiming for consistent year-over-year revenue increases and enhanced profitability, driven by new sales, cross-sell, upsell, AI innovation, and expansion of the Wellness program.
Management projects sufficient liquidity for at least the next 12 months, with ongoing cost control and compliance with debt covenants.
Latest events from CareCloud
- AI-powered healthcare IT solutions drive growth, efficiency, and expanded market reach.MTBC
Investor presentation12 Mar 2026 - 2025 saw record revenue, positive EPS, and AI-driven growth, with strong 2026 outlook.MTBC
Q4 202512 Mar 2026 - Record free cash flow and profitability support dividend resumption and margin growth.MTBC
Q3 202415 Jan 2026 - Record 2024 profit, cash flow, and AI innovation drive 2025 growth outlook.MTBC
Q4 202425 Dec 2025 - AI-driven healthcare platform achieves record free cash flow and resumes strategic acquisitions.MTBC
15th Annual LD Micro Invitational 202524 Dec 2025 - AI Desk Agent automates 80% of patient calls, driving efficiency, savings, and rapid ROI.MTBC
Status Update18 Dec 2025 - Registering up to $250M in securities to drive healthcare tech growth and industry consolidation.MTBC
Registration Filing16 Dec 2025 - Vote proposed to increase authorized shares to 85 million, supporting growth and acquisitions.MTBC
Proxy Filing1 Dec 2025 - Shareholders to vote on aligning Series A Preferred Stock terms with Series B, including a dividend cut.MTBC
Proxy Filing1 Dec 2025